Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

FUSN

Fusion Pharmaceuticals (FUSN)

Fusion Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:FUSN
DateTimeSourceHeadlineSymbolCompany
06/10/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:FUSNFusion Pharmaceuticals Inc
06/10/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:FUSNFusion Pharmaceuticals Inc
06/10/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:FUSNFusion Pharmaceuticals Inc
06/04/20245:35PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FUSNFusion Pharmaceuticals Inc
06/04/20245:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FUSNFusion Pharmaceuticals Inc
06/04/20245:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FUSNFusion Pharmaceuticals Inc
06/04/20245:27PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FUSNFusion Pharmaceuticals Inc
06/04/20245:23PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FUSNFusion Pharmaceuticals Inc
06/04/20245:23PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FUSNFusion Pharmaceuticals Inc
06/04/20245:21PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FUSNFusion Pharmaceuticals Inc
06/04/20244:39PMEdgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:FUSNFusion Pharmaceuticals Inc
06/04/20244:37PMEdgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:FUSNFusion Pharmaceuticals Inc
06/04/20244:35PMEdgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:FUSNFusion Pharmaceuticals Inc
06/04/20244:32PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:FUSNFusion Pharmaceuticals Inc
06/04/20244:31PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:FUSNFusion Pharmaceuticals Inc
06/04/20244:29PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:FUSNFusion Pharmaceuticals Inc
06/04/20244:27PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:FUSNFusion Pharmaceuticals Inc
06/04/20244:26PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:FUSNFusion Pharmaceuticals Inc
06/04/20244:18PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FUSNFusion Pharmaceuticals Inc
06/04/20244:05PMPR Newswire (Canada)Acquisition of Fusion Pharmaceuticals CompletedNASDAQ:FUSNFusion Pharmaceuticals Inc
06/04/20244:05PMPR Newswire (US)Acquisition of Fusion Pharmaceuticals CompletedNASDAQ:FUSNFusion Pharmaceuticals Inc
05/31/20244:12PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FUSNFusion Pharmaceuticals Inc
05/31/20244:05PMPR Newswire (Canada)Fusion Pharmaceuticals Receives Final Court Order Approving ArrangementNASDAQ:FUSNFusion Pharmaceuticals Inc
05/31/20244:05PMPR Newswire (US)Fusion Pharmaceuticals Receives Final Court Order Approving ArrangementNASDAQ:FUSNFusion Pharmaceuticals Inc
05/29/20244:34PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FUSNFusion Pharmaceuticals Inc
05/29/20244:05PMPR Newswire (US)Fusion Pharmaceuticals Shareholders Approve Acquisition by AstraZenecaNASDAQ:FUSNFusion Pharmaceuticals Inc
05/29/20244:05PMPR Newswire (Canada)Fusion Pharmaceuticals Shareholders Approve Acquisition by AstraZenecaNASDAQ:FUSNFusion Pharmaceuticals Inc
05/10/20244:15PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:FUSNFusion Pharmaceuticals Inc
05/10/20247:54AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FUSNFusion Pharmaceuticals Inc
05/09/20244:14PMPR Newswire (US)Fusion Pharmaceuticals Announces First Patient Dosed in the Phase 2 Portion of the AlphaBreak Trial Evaluating FPI-2265 in Metastatic Castration-Resistant Prostate CancerNASDAQ:FUSNFusion Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:FUSN

Your Recent History

Delayed Upgrade Clock